Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

KROSKROS
9 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in KEROS THERAPEUTICS INC

AQR CAPITAL MANAGEMENT LLC holds 967,859 shares of KROS (KEROS THERAPEUTICS INC), worth $10.4M as of 2026-Q2. The position was increased (+138.1% shares). KROS represents 0.0% of AQR CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$10.4M

Current Shares

967,859

Total Value Change

+$10M

Total Shares Change

+960,268

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
967,859
+138.1%
$10.4M0.0%$10.70
45
2026-Q1
Increased
406,563
+125.2%
$4.5M0.0%$13.40
43
2025-Q4
Decreased
180,543
-11.7%
$3.7M0.0%$20.27
0
2025-Q3
Increased
204,351
+189.2%
$3.2M0.0%$15.95
43
2025-Q2
Increased
70,650
+219.2%
$943,1790.0%$13.49
40
2025-Q1
New
22,136
-
$225,5650.0%$10.79
32
2023-Q3
Exited
0
-100.0%
$00.0%$31.88
0
2023-Q2
Increased
11,441
+50.7%
$459,6990.0%$39.87
33
2023-Q1
New
7,591
-
$324,1360.0%$42.13
33

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used